MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s208263
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway

OncoTargets and Therapy
OncologyPharmacology
2019English

Alantolactone Suppresses Human Osteosarcoma Through the PI3K/AKT Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

TSSC3 Promotes Autophagy via Inactivating the SRC-Mediated PI3K/Akt/mTOR Pathway to Suppress Tumorigenesis and Metastasis in Osteosarcoma, and Predicts a Favorable Prognosis

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

MicroRNA-145 Inhibits Growth of Laryngeal Squamous Cell Carcinoma by Targeting the PI3K/Akt Signaling Pathway

Cancer Management and Research
Oncology
2019English

PI3K-PKB/Akt Pathway

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2012English

MicroRNA miR-451 Downregulates the PI3K/AKT Pathway Through CAB39 in Human Glioma

International Journal of Oncology
Cancer ResearchOncology
2011English

MicroRNA‑448 Inhibits the Progression of Retinoblastoma by Directly Targeting ROCK1 and Regulating PI3K/AKT Signalling Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

Tizanidine Hydrochloride Exhibits a Cytotoxic Effect on Osteosarcoma Cells Through the PI3K/AKT Signaling Pathway

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

MicroRNA-511 Inhibits Malignant Behaviors of Breast Cancer by Directly Targeting SOX9 and Regulating the PI3K/Akt Pathway

International Journal of Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy